Walgreens and S&P 500 Performance During 2007-08 Crisis. WBA stock declined from nearly $27 in September 2007 (pre-crisis peak) to $17 in March 2009 (as the markets bottomed out), implying it lost ...

WBA Stock Price Performance. Walgreens shares have struggled in the past year, plummeting 62.9% compared with the industry’s 47.2% decline and the S&P 500’s 25.9% growth.

Deerfield, Illinois-based Walgreens Boots Alliance, Inc. (WBA), is an integrated healthcare, pharmacy, and retail company. With a market cap of $8.2 billion, Walgreens operates through the U.S ...

WBA stock still up for 2025. While today’s drop is significant, it’s important to note that Walgreens stock is still up about 3.8% year-to-date, largely due to the 25% jump earlier in the month.

It isn't a bad business model, but the U.S. market is largely saturated. Competition is fierce, and more and more ways to buy medication now exist, exacerbating the issue. They include grocery stores, ...

Walgreens stock jumps 27% after earnings surpass estimates. ... Adjusted operating income increased 17.9% to $168 million, led by strong retail performance in Boots UK and growth in Germany, ...

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement ...

Walgreens' stock price isn't going anywhere fast. Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.

The stock closed Friday at $8.48, down 3.75 percent from Thursday, continuing a broader downward trend. Walgreens-Boots shares are down 66 percent over the past year and trading at their lowest ...

Walgreens' stock price isn't going anywhere fast. Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.